Francheska Colon-Gonzalez

Summary

Affiliation: Thomas Jefferson University
Country: USA

Publications

  1. pmc Obesity pharmacotherapy: what is next?
    Francheska Colon-Gonzalez
    Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, Philadelphia, PA, United States
    Mol Aspects Med 34:71-83. 2013
  2. pmc Regulation of appetite to treat obesity
    Gilbert W Kim
    Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, 132 S 10th Street, 1170 Main, Philadelphia, PA 19107, USA
    Expert Rev Clin Pharmacol 4:243-59. 2011
  3. pmc Obesity-Induced Colorectal Cancer Is Driven by Caloric Silencing of the Guanylin-GUCY2C Paracrine Signaling Axis
    Jieru E Lin
    Division of Clinical Pharmacology, Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, Philadelphia, Pennsylvania
    Cancer Res 76:339-46. 2016

Collaborators

  • Adam E Snook
  • Jieru E Lin
  • Gilbert W Kim
  • Scott A Waldman
  • Terry M Hyslop
  • Amanda Aing
  • Tingting Zhan
  • Richard S Blumberg
  • Brian Stoecker
  • ERIK BLOMAIN
  • Justin Rock
  • Michal Tomczak
  • Michael A Valentino

Detail Information

Publications3

  1. pmc Obesity pharmacotherapy: what is next?
    Francheska Colon-Gonzalez
    Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, Philadelphia, PA, United States
    Mol Aspects Med 34:71-83. 2013
    ..It should serve as a roadmap to establish expectations for the near future for anti-obesity drug development...
  2. pmc Regulation of appetite to treat obesity
    Gilbert W Kim
    Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, 132 S 10th Street, 1170 Main, Philadelphia, PA 19107, USA
    Expert Rev Clin Pharmacol 4:243-59. 2011
    ..This article presents the efficacy and safety of these anti-obesity drugs...
  3. pmc Obesity-Induced Colorectal Cancer Is Driven by Caloric Silencing of the Guanylin-GUCY2C Paracrine Signaling Axis
    Jieru E Lin
    Division of Clinical Pharmacology, Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, Philadelphia, Pennsylvania
    Cancer Res 76:339-46. 2016
    ....